• Cannabis company, Primo Nutraceuticals (CSE:PRMO) has received approval to sell its Primo Lemon Hand Sanitiser on Amazon.com 
  • The company applied for permission two months ago, but was thwarted by restrictions on Amazon’s Personal Safety & Household category
  • However Primo has finally gained approval from the e-commerce giant to sell its sanitiser on the site
  • The development is timely, as the company’s first shipment of sanitiser left the manufacturer on May 29
  • Primo Nutraceuticals (PRMO) is down 16.67 per cent and is currently trading at C$0.025 cents per share

Cannabis company, Primo Nutraceuticals (CSE:PRMO) has received approval to sell its Primo Lemon Hand Sanitiser on Amazon.com.

The company first applied for permission to sell on the site approximately two months ago. This was a reaction to the unprecedented increase in demand for hand sanitiser, which resulted from the COVID-19 pandemic.

Amazon granted Primo a Seller Central account, but initially denied its application to sell hand sanitiser on its marketplace forum. At the time, the e-commerce giant was no longer approving new listings in the Personal Safety & Household category. 

Amazon started restricting the types of sellers who could sell health and sanitation products in early March. This included sellers of face masks, hand sanitisers, disinfecting wipes and sprays, isopropyl alcohol, and other products.

Despite the initial setback, Primo Nutraceuticals persevered in hopes of gaining permission to sell on the site. The company conducted multiple discussions with customer care as part of its efforts.

Primo has now met all necessary criteria as a licensed establishment, with a product licensed and approved by Health Canada. As a result, the company finally gained permission to sell the hand sanitiser in Amazon’s Personal Safety & Household category.

This development could not have come at a better time for the company. Primo’s first shipment of sanitiser was picked up from the manufacturer on May 29, 2020. 

The company expects the first delivery of its hand sanitiser to occur later this week. With COVID-19 cases continuing to climb in North America, demand for sanitiser is likely to remain high for some time.

Primo Nutraceuticals (PRMO) is down 16.67 per cent and is currently trading atC$0.025 per share at 11:22am EDT.

More From The Market Online
Cannabis Report image of farmed cannabis plants

The Market Online’s Weekly Cannabis Report – July 26, 2024

Tilray Oral Solution THC10:CBD10 cannabis extract, aka Tilray Solução Oral THC10:CBD10, has been approved for medical use in Portugal.
medical branch logo

Tilray approved for third medical cannabis product in Portugal

Tilray Medical, a subsidiary of Tilray Brands (TSX:TLRY) has been approved for a new medical cannabis extract in Portugal.